Medical cannabis stocks face funding scrutiny
medical cannabis stocks in London face funding and regulatory scrutiny as investors demand clearer cash metrics, approvals and short-term revenue outlook
Tag: stocks
AI Demand Boosts cannabis stocks on London Market
cannabis stocks listed in London gain investor interest as AI demand and digital infrastructure create measurable revenue through automation, software and
Jim Cramer Backs trulieve cannabis as ‘Terrific Spec’
Jim Cramer calls trulieve cannabis a ‘terrific spec’ and praises its brand. TRLV operates dispensaries and home delivery for flower, concentrates and
Trulieve Lists on NYSE After Schedule III Shift
trulieve nyse listing opens institutional access to medical cannabis, boosting liquidity and analyst coverage while only medical operations are publicly
Aurora Cannabis misses Q4 earnings targets amid mixed outlook
Aurora Cannabis Inc. (ACB) reported quarterly earnings of $0.07 per share for the period ending March 2025, falling short of…
Aurora Cannabis Stock Drops Amid Decline in International Sales
Aurora Cannabis, a major player in the Canadian cannabis market, experienced a sharp decline in its stock value on Wednesday,…
Investors Eye Turning Point Brands, Canopy Growth, Indivior
As of June 9, 2025, investors are focusing on three notable cannabis stocks: Turning Point Brands, Canopy Growth, and Indivior,…
Seven cannabis stocks show promise for investors
As of May 28th, several cannabis stocks have garnered attention from investors, according to MarketBeat’s stock screener tool. The companies…
Canopy Growth reports lower Q4 earnings, stock drops 21%
Canopy Growth Corp (NASDAQ: CGC) announced its fourth-quarter earnings for 2025 on Thursday, revealing a significant decline in sales. The…
Investors Eye Key Cannabis Stocks for May 2023
As the cannabis market continues to evolve, investors are closely monitoring several key stocks this May. Companies like Gibraltar Industries,…